These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35261123)

  • 1. SARS-CoV-2 vaccination and practical points in psoriasis patients: A narrative review.
    Aryanian Z; Balighi K; Hatami P; Goodarzi A; Mohandesi NA; Afshar ZM
    Dermatol Ther; 2022 May; 35(5):e15430. PubMed ID: 35261123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 (COVID-19) vaccination in dermatology patients on immunomodulatory and biologic agents: Recommendations from the Australasian Medical Dermatology Group.
    Wang C; Rademaker M; Tate B; Baker C; Foley P
    Australas J Dermatol; 2021 May; 62(2):151-156. PubMed ID: 33786833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple COVID reinfections in a vaccinated psoriatic patient receiving adalimumab.
    Zargari O; Azimi SZ
    J Dermatolog Treat; 2023 Dec; 34(1):2149237. PubMed ID: 36384391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 vaccine safety and efficacy in patients with immune-mediated inflammatory disease: Review of available evidence.
    Wack S; Patton T; Ferris LK
    J Am Acad Dermatol; 2021 Nov; 85(5):1274-1284. PubMed ID: 34363909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No impact of immunomodulatory treatments on SARS-CoV-2 (COVID-19) vaccine outcomes: A cross-sectional analysis of biologic and small molecule inhibitors used for psoriasis and hidradenitis suppurativa patients from the Epic Cosmos database.
    Lee BR; Brostek AR; Kaffenberger BH
    J Am Acad Dermatol; 2024 Jul; 91(1):100-102. PubMed ID: 38490372
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact of biologic therapy for moderate-to-severe psoriasis on the immune responses to SARS-CoV-2 infection and vaccination.
    Favaro R; Formai A; Pavia G; Gargiulo L; Avagliano J; Valenti M; Facheris P; Salsano B; Latorre RV; Bellinato F; Gisondi P; Narcisi A; Costanzo A
    Br J Dermatol; 2023 Oct; 189(5):635-637. PubMed ID: 37463513
    [No Abstract]   [Full Text] [Related]  

  • 7. Case of Exacerbation of Psoriasis Following COVID-19 Vaccination During Treatment with Brodalumab, Which Resulted in Secondary Failure.
    Tokuyama M; Mabuchi T
    Tokai J Exp Clin Med; 2023 Dec; 48(4):136-138. PubMed ID: 37981850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 Among Patients with Psoriasis: A Single-Center Retrospective Cross-Sectional Study.
    Kaya Ö; Keskinkaya Z; Mermutlu SI; Kılıç SO; Çakır H
    Infect Dis Clin Microbiol; 2023 Jun; 5(2):127-135. PubMed ID: 38633013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter re: SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis.
    Baba A; Tokunaga T; Sakasegawa K; Kanekura T; Tsubouchi H
    Eur J Cancer; 2023 Jul; 187():96-98. PubMed ID: 37130465
    [No Abstract]   [Full Text] [Related]  

  • 10. New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge.
    Potestio L; Battista T; Cacciapuoti S; Ruggiero A; Martora F; Fornaro L; Camela E; Megna M
    Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [COVID-19 vaccination in patients suffering from respiratory diseases. Update of 25th June 2021].
    Blanchard E; Ozier A; Janssen C; Wyplosz B; Andrejak C
    Rev Mal Respir; 2021 Sep; 38(7):780-793. PubMed ID: 34362608
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe coronary artery spasm after administration of a 5-hydroxytryptamine type 1 receptor agonist and SARS-CoV2 vaccination: Comment.
    Kleebayoon A; Wiwanitkit V
    Acta Cardiol; 2023 Oct; 78(8):974. PubMed ID: 36729020
    [No Abstract]   [Full Text] [Related]  

  • 13. Plaque Psoriasis Exacerbation and COVID-19 Vaccination: Assessing the Characteristics of the Flare and the Exposome Parameters.
    Karampinis E; Papadopoulou MM; Chaidaki K; Georgopoulou KE; Magaliou S; Roussaki Schulze AV; Bogdanos DP; Zafiriou E
    Vaccines (Basel); 2024 Feb; 12(2):. PubMed ID: 38400161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of COVID-19 Vaccination on Disease Severity in Patients With Stable Plaque Psoriasis: A Cross-sectional Study.
    Bhandari A; Narang T; Subburaj K; Dogra S; Handa S
    Cutis; 2023 Sep; 112(3):137-138. PubMed ID: 37903389
    [No Abstract]   [Full Text] [Related]  

  • 15. New-onset guttate psoriasis secondary to COVID-19.
    Rouai M; Rabhi F; Mansouri N; Jaber K; Dhaoui R
    Clin Case Rep; 2021 Jul; 9(7):e04542. PubMed ID: 34336212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythrodermic Psoriasis Following SARS-CoV-2 Infection.
    Agharbi FZ; Basri G; Nejjari S; Chiheb S
    Actas Dermosifiliogr; 2024 Feb; 115(2):T202-T203. PubMed ID: 38048941
    [No Abstract]   [Full Text] [Related]  

  • 17. Erythrodermic Psoriasis Following SARS-CoV-2 Infection.
    Agharbi FZ; Basri G; Nejjari S; Chiheb S
    Actas Dermosifiliogr; 2024 Feb; 115(2):202-203. PubMed ID: 35868545
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical and epidemiological features of psoriasis exacerbations in children with SARS-CoV-2 infection.
    Skrek S; Di Lernia V; Beauchet A; Bursztejn AC; Belloni Fortina A; Lesiak A; Thomas J; Brzezinski P; Topkarci Z; Murashkin N; Torres T; Epishev R; Chiriac A; McPherson T; Akinde M; Maruani A; Luna PC; Vidaurri de la Cruz H; Mallet S; Leducq S; Sergeant M; Zitouni J; Mahil SK; Smith CH; Flohr C; Bachelez H; Mahé E;
    J Eur Acad Dermatol Venereol; 2023 Oct; 37(10):e1192-e1195. PubMed ID: 37326146
    [No Abstract]   [Full Text] [Related]  

  • 19. SARS-CoV-2 and guttate psoriasis: A case report and review of literature.
    Ali E; Mohamed A; Abuodeh J; Albuni MK; Al-Mannai N; Salameh S; Petkar M; Habas E
    Clin Case Rep; 2021 Jul; 9(7):e04568. PubMed ID: 34295501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial: Challenges of COVID-19 in dermatology patients on immunosuppression: risk, outcome, vaccination and beyond, volume II.
    Patsatsi A; Daneshpazhooh M; Tavakolpour S; Mahmoudi H; Murrell DF
    Front Med (Lausanne); 2023; 10():1268285. PubMed ID: 37692778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.